Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of circulating tumor cell clusters in patients with metastatic hormone-sensitive prostate cancer receiving a gonadotropin-releasing hormone antagonist: A pilot study.
Kohada Y, Kusumoto H, Kukimoto T, Mikami J, Ito J, Asano K, Yaegashi T, Nakagawara K, Teishima J, Kaiho Y, Hinata N, Nakamura Y, Sato M. Kohada Y, et al. Among authors: hinata n. Asian J Urol. 2023 Apr;10(2):210-212. doi: 10.1016/j.ajur.2022.03.009. Epub 2022 Jul 22. Asian J Urol. 2023. PMID: 36942117 Free PMC article. No abstract available.
Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.
Yonese J, Hinata N, Masui S, Nakai Y, Shirotake S, Takeuchi A, Inamoto T, Nozawa M, Ueda K, Etsunaga T, Osawa T, Uemura M, Kimura G, Numakura K, Yamana K, Miyake H, Fukasawa S, Morishima N, Ito H, Uemura H. Yonese J, et al. Among authors: hinata n. Int J Urol. 2023 Sep;30(9):762-771. doi: 10.1111/iju.15206. Epub 2023 May 29. Int J Urol. 2023. PMID: 37248753 Free PMC article.
Genetic Risk of Primary Aldosteronism and Its Contribution to Hypertension: A Cross-Ancestry Meta-Analysis of Genome-Wide Association Studies.
Naito T, Inoue K, Sonehara K, Baba R, Kodama T, Otagaki Y, Okada A, Itcho K, Kobuke K, Kishimoto S, Yamamoto K; BioBank Japan; Morisaki T, Higashi Y, Hinata N, Arihiro K, Hattori N, Okada Y, Oki K. Naito T, et al. Among authors: hinata n. Circulation. 2023 Apr 4;147(14):1097-1109. doi: 10.1161/CIRCULATIONAHA.122.062349. Epub 2023 Feb 21. Circulation. 2023. PMID: 36802911 Free PMC article.
Novel quantitative software for automatically excluding red bone marrow on whole-body magnetic resonance imaging in patients with metastatic prostate cancer: A pilot study.
Kohada Y, Satani N, Kaiho Y, Iwamura H, Sakamoto T, Kusumoto H, Kukimoto T, Oikawa M, Mikami J, Ito J, Matsuura T, Hinata N, Koyama K, Sato M. Kohada Y, et al. Among authors: hinata n. Int J Urol. 2023 Apr;30(4):356-364. doi: 10.1111/iju.15124. Epub 2022 Dec 20. Int J Urol. 2023. PMID: 36539348
Bioabsorbable zinc alloys for use in urological surgery.
Takanori S, Hinata N, Kobayashi R, Nakatsuji T, Okamura Y, Furukawa J, Nakano Y, Mukai T, Fujisawa M. Takanori S, et al. Among authors: hinata n. World J Urol. 2023 Apr;41(4):1181-1186. doi: 10.1007/s00345-023-04342-x. Epub 2023 Mar 16. World J Urol. 2023. PMID: 36929408
Management of patients with advanced prostate cancer in Japan: 'real-world' consideration of the results from the Advanced Prostate Cancer Consensus Conference.
Fujita K, Suzuki H, Hinata N, Miura Y, Edamura K, Tabata KI, Arai G, Matsubara N, Yasumizu Y, Kosaka T, Oya M, Sugimoto M. Fujita K, et al. Among authors: hinata n. Transl Androl Urol. 2022 Dec;11(12):1771-1785. doi: 10.21037/tau-22-396. Transl Androl Urol. 2022. PMID: 36632151 Free PMC article. Review.
174 results